RCS from human platelets: Is it only thromboxane?

This publication has 10 references indexed in Scilit:

• Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
  Published by Wiley ,1983
• Imidazole-induced potentiation of the contractile response to various agonists in vascular smooth muscle
  European Journal of Pharmacology, 1982
• Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation
  Thrombosis Research, 1981
• UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity
  Thrombosis Research, 1981
• INHIBITION OF THROMBOXANE SYNTHETASE DOES NOT NECESSARILY PREVENT PLATELET AGGREGATION
  The Lancet, 1981
• Different sensitivities of prostaglandin-cyclooxygenases in blood platelets and coronary arteries against non-steroidal antiinflammatory drugs
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1980
• : A selective inhibitor of thromboxane synthetase
  Prostaglandins, 1977
• Prostaglandin Endoperoxides IX. Characterization of Rabbit Aorta Contracting Substance (RCS) from Guinea Pig Lung and Human Platelets
  Acta Physiologica Scandinavica, 1975
• Platelet Aggregation induced by Arachidonic Acid is accompanied by Release of Potential Inflammatory Mediators distinct from PGE2 and PGF2
  Nature New Biology, 1973
• Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
  Nature, 1969